Ensysce Biosciences, Inc. (ENSC)
0.4705
-0.04
(-7.93%)
USD |
NASDAQ |
Oct 23, 16:00
0.465
-0.01
(-1.17%)
After-Hours: 20:00
Ensysce Biosciences Market Cap : 7.635M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 7.635M |
| October 22, 2026 | 8.292M |
| October 21, 2026 | 8.438M |
| October 20, 2026 | 8.091M |
| October 19, 2026 | 8.161M |
| October 16, 2026 | 8.411M |
| October 15, 2026 | 9.702M |
| October 14, 2026 | 9.104M |
| October 13, 2026 | 9.290M |
| October 12, 2026 | 9.021M |
| October 09, 2026 | 8.552M |
| October 08, 2026 | 7.432M |
| October 07, 2026 | 6.968M |
| October 06, 2026 | 6.975M |
| October 05, 2026 | 6.799M |
| October 02, 2026 | 6.410M |
| October 01, 2026 | 6.488M |
| September 30, 2026 | 6.747M |
| September 29, 2026 | 6.767M |
| September 28, 2026 | 6.509M |
| September 25, 2026 | 6.691M |
| September 24, 2026 | 6.493M |
| September 23, 2026 | 6.726M |
| September 22, 2026 | 6.962M |
| September 21, 2026 | 6.833M |
| Date | Value |
|---|---|
| September 18, 2026 | 7.434M |
| September 17, 2026 | 7.343M |
| September 16, 2026 | 7.267M |
| September 15, 2026 | 7.328M |
| September 14, 2026 | 7.812M |
| September 11, 2026 | 7.901M |
| September 10, 2026 | 8.372M |
| September 09, 2026 | 7.698M |
| September 08, 2026 | 7.676M |
| September 04, 2026 | 7.395M |
| September 03, 2026 | 7.140M |
| September 02, 2026 | 7.186M |
| September 01, 2026 | 6.298M |
| August 31, 2026 | 6.372M |
| August 28, 2026 | 6.489M |
| August 27, 2026 | 6.475M |
| August 26, 2026 | 6.686M |
| August 25, 2026 | 6.540M |
| August 24, 2026 | 5.858M |
| August 21, 2026 | 6.058M |
| August 20, 2026 | 6.131M |
| August 19, 2026 | 6.296M |
| August 18, 2026 | 6.248M |
| August 17, 2026 | 6.111M |
| August 14, 2026 | 6.489M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 8.189B |
| Oncolytics Biotech, Inc. | 62.61M |
| Sangamo Therapeutics, Inc. | 47.64M |
| Sarepta Therapeutics, Inc. | 1.873B |
| Anixa Biosciences, Inc. | 103.41M |
Market Cap Related Metrics
| PS Ratio | 0.6913 |
| Price | 0.4705 |
| Earnings Yield | -586.5% |